Microbot Medical (MBOT) vs Outset Medical (OM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Microbot Medical (MBOT) has outperformed Outset Medical (OM) over the past year, losing 65.3% versus a loss of 74.1%. Over five years, MBOT leads with a -84.4% price change compared with -99.4% for OM. Outset Medical is the larger company by market cap ($76.9 million vs $71.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MBOT | OM |
|---|---|---|
| Share price | $1.07 | $4.09 |
| Market cap | $71.87M | $76.88M |
| 1-day change | -4.46% | -2.85% |
| YTD return | -44.00% | +10.24% |
| 1-year return | -65.33% | -74.13% |
| 5-year return | -84.38% | -99.44% |
| EPS (TTM) | $-0.25 | $-4.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.17 | $15.94 |
| 52-week low | $1.05 | $2.84 |
| Distance from 52-week high | -66.25% | -74.34% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +491.59% | +87.53% |
| Average volume | 649.10K | 158.75K |
| Shares outstanding | 67.16M | 18.80M |
| Employees | 43 | 310 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Microbot Medical
MBOT stock →Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space.
Healthcare · Medical Devices · 43 employees
About Outset Medical
OM stock →Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.
Healthcare · Medical Devices · 310 employees
MBOT vs OM FAQ
Which is bigger, Microbot Medical or Outset Medical?
Outset Medical (OM) is larger, with a market capitalization of $76.88M compared with $71.87M for Microbot Medical (MBOT).
Which stock has performed better over the past year, MBOT or OM?
MBOT returned -65.33% over the past 12 months, compared with -74.13% for OM (price return, excluding dividends). Past performance does not predict future results.
Are Microbot Medical and Outset Medical in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.